Clinical trial / 2009
Daily Lactobacillus casei strain Shirota for two months significantly reduced anxiety symptoms in chronic fatigue syndrome patients.
In this pilot study, 39 chronic fatigue syndrome patients were randomized to receive either 24 billion colony forming units of Lactobacillus casei strain Shirota (LcS) or a placebo daily for two months. Patients provided stool samples and completed the Beck Depression and Beck Anxiety Inventories before and after treatment. There was a significant rise in both Lactobacillus and Bifidobacteria in the LcS group, along with a significant decrease in anxiety symptoms compared to controls (p = 0.01).
- Study type
- Randomized, double-blind, placebo-controlled pilot study
- Who was studied
- 39 chronic fatigue syndrome (CFS) patients
- What was measured
- Stool microflora, Beck Depression Inventory, and Beck Anxiety Inventory scores
THE PAPER
A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome.
Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM, Logan AC. Gut Pathog, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.